Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -15.59%947.51K | -37.15%953.75K | -16.57%926.24K | 26.25%5.38M | -9.57%1.63M | 44.97%1.12M | 106.92%1.52M | 16.62%1.11M | -28.21%4.26M | 60.87%1.8M |
| Operating revenue | -15.59%947.51K | -37.15%953.75K | -16.57%926.24K | 26.25%5.38M | -9.57%1.63M | 44.97%1.12M | 106.92%1.52M | 16.62%1.11M | -28.21%4.26M | 60.87%1.8M |
| Cost of revenue | 64.70%552.42K | 21.52%529.37K | 20.64%471.13K | -13.77%2.52M | -24.84%1.36M | -9.98%335.42K | 24.27%435.64K | -0.41%390.51K | 82.35%2.92M | 213.58%1.81M |
| Gross profit | -49.80%395.09K | -60.77%424.39K | -36.76%455.11K | 113.62%2.86M | 4,555.70%270.24K | 95.95%787.09K | 182.61%1.08M | 28.54%719.63K | -69.10%1.34M | -101.12%-6.07K |
| Operating expense | -15.76%552.98K | -3.29%571.59K | -5.38%505.05K | 31.04%2.67M | 41.78%886.92K | 65.99%656.45K | 24.51%591K | -0.83%533.75K | -32.45%2.04M | -30.99%625.57K |
| Selling and administrative expenses | -7.51%248.58K | 5.06%270.53K | 18.30%265.1K | 16.84%1.02M | 7.71%273.91K | 36.67%268.76K | 16.80%257.49K | 9.20%224.08K | 2.12%876.62K | -20.35%254.31K |
| -General and administrative expense | -7.51%248.58K | 5.06%270.53K | 18.30%265.1K | 16.84%1.02M | 7.71%273.91K | 36.67%268.76K | 16.80%257.49K | 9.20%224.08K | 2.12%876.62K | -20.35%254.31K |
| Research and development costs | --0 | ---- | ---- | -84.04%1.06K | --0 | --1.06K | --0 | ---- | -95.25%6.65K | --0 |
| Other operating expenses | -21.27%304.4K | -9.73%301.06K | -22.51%239.96K | 42.50%1.64M | 65.11%613K | 94.46%386.63K | 34.72%333.51K | -7.01%309.67K | -42.81%1.15M | -36.78%371.26K |
| Operating profit | -220.86%-157.89K | -129.99%-147.2K | -126.87%-49.94K | 127.32%190.64K | 2.37%-616.68K | 2,000.98%130.64K | 634.18%490.8K | 759.76%185.88K | -153.00%-697.89K | -73.70%-631.64K |
| Net non-operating interest income (expenses) | 88.93%-883 | -26.97%-499 | 405.88%602 | 38.40%-10.24K | 96.47%-2K | -2,497.07%-7.97K | -101.61%-393 | -99.13%119 | -121.54%-16.62K | -170.68%-56.58K |
| Non-operating interest income | ---- | ---- | -7.82%1.08K | ---- | ---- | ---- | ---- | -92.82%1.18K | --0 | ---- |
| Non-operating interest expense | ---- | ---- | ---- | -46.48%7.99K | ---- | ---- | ---- | -76.02%531 | 2,543.01%14.93K | ---- |
| Total other finance cost | -88.93%883 | 26.97%499 | -54.40%482 | 33.00%2.25K | -114.40%-6K | 2,497.07%7.97K | 101.61%393 | 115.71%1.06K | -37.18%1.69K | 26,291.19%41.64K |
| Other net income (expenses) | -353.71%-4.46M | -4.5M | 40K | -481,762.75%-983K | ||||||
| Special income (charges) | --0 | --0 | --0 | -353.71%-4.46M | -357.78%-4.5M | --0 | --0 | --40K | ---983K | ---983K |
| -Less:Impairment of capital assets | ---- | ---- | ---- | 346.43%4.5M | ---- | ---- | ---- | ---- | --1.01M | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---40K | --0 | ---- | ---- | ---40K | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --25K | ---- |
| Income before tax | -229.43%-158.77K | -130.12%-147.7K | -121.83%-49.34K | -152.11%-4.28M | -206.28%-5.12M | 1,975.22%122.67K | 826.38%490.41K | 540.21%226K | -221.78%-1.7M | -417.02%-1.67M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 96.29%-6.92K | ||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -229.43%-158.77K | -130.12%-147.7K | -121.83%-49.34K | -152.11%-4.28M | -207.56%-5.12M | 1,975.22%122.67K | 758.89%490.41K | 540.21%226K | -207.43%-1.7M | -1,115.31%-1.66M |
| Net income continuous operations | -229.43%-158.77K | -130.12%-147.7K | -121.83%-49.34K | -152.11%-4.28M | -207.56%-5.12M | 1,975.22%122.67K | 758.89%490.41K | 540.21%226K | -207.43%-1.7M | -1,115.31%-1.66M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -229.43%-158.77K | -130.12%-147.7K | -121.83%-49.34K | -152.11%-4.28M | -207.56%-5.12M | 1,975.22%122.67K | 758.89%490.41K | 540.21%226K | -207.43%-1.7M | -1,115.31%-1.66M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -229.43%-158.77K | -130.12%-147.7K | -121.83%-49.34K | -152.11%-4.28M | -207.56%-5.12M | 1,975.22%122.67K | 758.89%490.41K | 540.21%226K | -207.43%-1.7M | -1,115.31%-1.66M |
| Diluted earnings per share | 0 | 0 | 0 | -0.01 | -15,725.00%-0.01 | 0 | 0 | 0 | 0 | 110.92%0.0001 |
| Basic earnings per share | 0 | 0 | 0 | -0.01 | -15,725.00%-0.01 | 0 | 0 | 0 | 0 | 110.92%0.0001 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.